NACCME/Princeton CMENACCME/Princeton CME
First ReportManaged Care ConsultantCoalition of Rheumatology Educators (CORE)CME ForumCE ForumNP/PA ConsultantPrinceton Teleconference Series

Testing Center

Adolescent Immunization Update Opportunities to Prevent Pertussis, Meningococcal Disease, and HPV

Jointly sponsored by Medical Education Collaborative, Inc (MEC) and Princeton CME

Purpose Statement

This activity is designed to educate pediatricians and pediatric and adolescent primary care professionals on the disease burden, potential barriers to successful immunization, Advisory Committee on Immunization Practices (ACIP) recommendations, and best practices for the prevention of meningococcal disease, pertussis, and human papillomavirus (HPV) in the adolescent population. By implementing recommended strategies in clinical practice, adolescent immunization rates may increase, thus leading to a reduction in disease incidence.

Target Audience

This activity is designed for pediatricians and pediatric and adolescent primary care physicians and nurses.

Learning Objectives

After completing this activity, participants should be able to:

  • Summarize the clinical and economic burden of pertussis, meningococcal disease, and HPV in the adolescent population
  • Identify potential barriers to adolescent immunization and review the importance of timely vaccination in this high-risk group
  • Recognize opportunities for vaccine administration in healthy adolescents, particularly among younger adolescents 11 to 12 years of age
  • Adopt into clinical practice updated ACIP recommendations for adolescent vaccination

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity—including Question and Answer session—complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants seeking CME credit who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Participants seeking CNE credit who successfully complete the post-test and evaluation form online will receive documentation of credit by mail within 6 weeks.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release date: May 14, 2008

Expiration date: May 14, 2009

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The presentation slides, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc (MEC) and Princeton CME. MEC is accredited by the ACCME to provide continuing medical education for physicians.

MEC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding the ACCME accreditation of this activity, please contact MEC at 866-420-3252.

CNE Accreditation

Medical Education Collaborative, Inc (MEC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity for 1.0 contact hour is provided by MEC.

MEC is approved by the California Board of Registered Nursing, Provider Number 129909 for 1.0 contact hour.

Grant Support

Supported by an unrestricted educational grant from sanofi pasteur.

Participating Faculty

Presenter

Sharon G. Humiston, MD, MPH
Associate Professor of Emergency Medicine and Pediatrics
Department of Emergency Medicine
University of Rochester School of Medicine & Dentistry
Rochester, New York

Independent Clinical Reviewer

Stanley J. Schaffer, MD
Associate Professor of Pediatrics and Community and Preventive Medicine
University of Rochester School of Medicine & Dentistry
Rochester, New York

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of Medical Education Collaborative, Inc (MEC) and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of MEC and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Humiston: Advisory board—GlaxoSmithKline, Merck & Co., Inc; Grant/Research support—Centers for Disease Control and Prevention, National Immunization Program, National Institutes of Health; Speaker’s bureau—Merck & Co., Inc, sanofi pastuer
Dr. Schaffer disclosed no relevant financial relationships with any commercial interests.

Planning Committee employees of MEC, the accredited provider for this activity; Randy Robbin, Rich Keenan and John Savage, Princeton CME; and Jessica Brown, Kristin Dickie, and Mary Johnson, Princeton Media Communications have disclosed that they have no relevant financial relationships with any commercial interest.

MEC and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.

The following off-label/unapproved drugs or devices are discussed: Tdap administration to persons without a history of DTaP.

With approval from MEC, this continuing medical education activity includes medication brand names for participant clarity purposes only, due to the presence of different branded versions of the same agent. No product promotion or recommendation should be inferred.

Privacy Policy

Medical Education Collaborative, Inc (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

MEC and Princeton CME maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. 

Publisher’s Note

The opinions expressed in this educational activity are those of the presenters and are not attributable to the sponsor or the publisher, editor, or advisory board of Medical Education Collaborative, Inc (MEC) and Princeton Media Communications. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Copyright© Princeton CME. All Rights Reserved. Permission for accreditation use granted May 14, 2008 to May 14, 2009 to Medical Education Collaborative, Inc (MEC).



   

©Copyright 2003-2008 NACCME-Princeton CME   Privacy Policy
Hardware/Software Requirements Disclosure Statement